The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

PURPOSE: To evaluate the safety of live attenuated influenza vaccine (LAIV) in children 2 through 17 years of age. METHODS: The study was conducted in 6 large integrated health care organizations participating in the Vaccine Safety Datalink (VSD). Trivalent LAIV safety was assessed in children who r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmacoepidemiol Drug Saf
Autores principales: Daley, Matthew F., Clarke, Christina L., Glanz, Jason M., Xu, Stanley, Hambidge, Simon J., Donahue, James G., Nordin, James D., Klein, Nicola P., Jacobsen, Steven J., Naleway, Allison L., Jackson, Michael L., Lee, Grace, Duffy, Jonathan, Weintraub, Eric
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437673/
https://ncbi.nlm.nih.gov/pubmed/29148124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4349
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares